Showing results (101-110 of 190) with videos related to
Sort By:
Pageof 19
British Journal of Cancer|April 22, 2023
Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumorsJason J Luke, Marwan Fakih, Charles Schneider, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2019
Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201)Jason J Luke, Daniel J Olson, Jacob B Allred, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2022
Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal MelanomaRichard D Carvajal, Paul Nathan, Joseph J Sacco, et al.Journal for Immunotherapy of Cancer|March 15, 2022
Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I studyAung Naing, John D Powderly, John J Nemunaitis, et al.Cancer Biotherapy & Radiopharmaceuticals|January 13, 2022
A Pilot Study of Hepatic Irradiation with Yttrium-90 Microspheres Followed by Immunotherapy with Ipilimumab and Nivolumab for Metastatic Uveal MelanomaDavid R Minor, Kevin B Kim, Ricky T Tong, et al.Journal for Immunotherapy of Cancer|February 20, 2025
Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumorsJason J Luke, David J Pinato, Dejan Juric, et al.Nature Communications|September 4, 2019
Tumor-reprogrammed resident T cells resist radiation to control tumorsAinhoa Arina, Michael Beckett, Christian Fernandez, et al.Cancer Chemotherapy and Pharmacology|February 13, 2015
Alliance A091103 a phase II study of the angiopoietin 1 and 2 peptibody trebananib for the treatment of angiosarcomaSandra P D' Angelo, Michelle R Mahoney, Brian A Van Tine, et al.The Journal of Clinical Investigation|May 15, 2023
Partial tumor irradiation plus pembrolizumab in treating large advanced solid tumor metastasesMark C Korpics, Benjamin E Onderdonk, Rebekah E Dadey, et al.Melanoma Research|September 14, 2018
Results from phase II trial of HSP90 inhibitor, STA-9090 (ganetespib), in metastatic uveal melanomaShalin Shah, Jason J Luke, Heather A Jacene, et al.Pageof 19